SFS
PRTK

Sowell Financial Services’s Paratek Pharmaceuticals, Inc. PRTK Stock Holding History

Sowell Financial Services’s Portfolio PRTK Stock Details PRTK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-100
Closed -$1K – 2971
2021
Q1 		$1K Hold
100
– – ﹤0.01% 3047
2020
Q4 		$1K Hold
100
– – ﹤0.01% 2652
2020
Q3 		$1K Buy
+100
New +$495 ﹤0.01% 2467
2019
Q4 		– Sell
-215
Closed -$1K – 2700
2019
Q3 		$1K Buy
+215
New +$860 ﹤0.01% 2347

Other funds holding PRTK

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
OFM
Omega Fund Management Boston, Massachusetts $163M AUM 107.06% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
RSCM
Rock Springs Capital Management Baltimore, Maryland $1.7B AUM 93.03% 1-Year Est. Return
BC
Bruce & Co Chicago, Illinois $350M AUM 33.5% 1-Year Est. Return
GAI
General American Investors New York $1.52B AUM 37.94% 1-Year Est. Return
A
Abingworth London, United Kingdom $307M AUM 93.47% 1-Year Est. Return
ACM
AIGH Capital Management Baltimore, Maryland $733M AUM 327.32% 1-Year Est. Return
GIM
Granahan Investment Management Waltham, Massachusetts $2.07B AUM 56.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Sowell Financial Services's PRTK Position: Q2 2021 in Review

Sowell Financial Services sold out of Paratek Pharmaceuticals, Inc. (PRTK) in Q2 2021, closing a stake of 100 shares — an estimated $1K sold.

Sowell Financial Services first reported a position in PRTK in Q3 2019 and held it in 4 quarters. The position peaked at $1K in Q1 2021. 116 funds tracked by Wall St. Rank hold PRTK as of Q2 2021.

  • Sowell Financial Services reported no remaining Paratek Pharmaceuticals, Inc. position as of Q2 2021 after selling out during the quarter.
  • Sowell Financial Services sold 100 Paratek Pharmaceuticals, Inc. shares in Q2 2021, an estimated $1K.
  • Sowell Financial Services first reported a position in Paratek Pharmaceuticals, Inc. in Q3 2019 and held it in 4 quarters.
  • Sowell Financial Services's Paratek Pharmaceuticals, Inc. position peaked at $1K in Q1 2021.
  • 116 funds tracked by Wall St. Rank held Paratek Pharmaceuticals, Inc. as of Q2 2021.

Based on Sowell Financial Services's 13F filing for Q2 2021, filed 5 Aug 2021.